Director Industry Relations Remote
UnitedHealth Group
- Location
- Eden Prairie, Minnesota
- Work model
- Remote
- Level
- Staff
- Salary
- $134.6k – $230.8k/yr
About this role
Optum is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find a culture guided by inclusion, talented peers, comprehensive benefits and career development opportunities. Come make an impact on the communities we serve as you help us advance health optimization on a global scale. Join us to start Caring. Connecting. Growing together. As a Director within our Industry Relations team, you will be responsible for advancing and strengthening our strategic partnerships with pharmaceutical companies while maintaining the competitiveness of the assigned manufacturer contracts, specifically for one or more of the key strategic, large, or high-risk partners. Our goal is to deliver high-quality, integrated services to promote optimal outcomes, economic savings, and outstanding provider and consumer experiences. As you do, you'll discover the resources, backing and opportunities that you'd expect from a Fortune 6 leader. You'll enjoy the flexibility to work remotely * from anywhere within the U.S. as you take on some tough challenges. For all hires in the Minneapolis or Washington, D.C. area, you will be required to work in the office a minimum of four days per week.
Primary Responsibilities
Negotiate and execute agreements with pharmaceutical companies while managing and developing relationships with national account leads for assigned accounts Strategize, develop, and recommend promoting formulary positioning that also drive economic value to the patient, provider, and care delivery organizations Collaborate with a cross functional internal teams (e.g. Rebates, Legal, Product and Clinical) to identify areas of opportunities Design and create rebate assumptions and forecast models, in partnership with others to resolve business problems that affect multiple functional areas, including audit data for accuracy and troubleshoot variances in modeling Understand, build, and maintain financial models, analytics, and reports for (Pharmacy and medical) rebate guarantee optimization, value-focused arrangements, and/or positive/negative impact to overall spend Leverage pharmaceutical, business, and regulatory knowledge to ensure proposed solutions and/or strategic partnerships are in compliance with all state and federal regulations Fully versed in all aspects of the contracts with assigned customers as well as ensuring ongoing contract performance through competitive environment management activities Communicate results of process development, financial impact, and analyses to appropriate stakeholder groups (e.g. Affordability, Pricing, Accrual, Accounting, Forecasting, Underwriting, Rebate Billing, Data Operations, Legal, and other internal customers) Create best practices to maximize efficiency, enhance data repositories (for data transfers and audits), and streamline process workflows with compressed and varying timelines Identify and implement solutions to support market access and reimbursement of pharmacotherapy products across different payment models Provides leadership to and is accountable for the performance and direction through multiple layers of management and senior level professional staff Any other duties that may be required by the department You'll be rewarded and recognized for your performance in an environment that will challenge you and give you clear direction on what it takes to succeed in your role as well as provide development for other roles you may be interested in.
Required Qualifications
8+ years of experience in managed health care or pharmacy benefit management, with a focus on pharmaceutical contracting negotiations and strategy development 8+ years of experience in financial analyses and economic models across medical and pharmacy claims, clinical data, and